Veeva Corp (VEEV): Koefisien rega marang pendapatan

Tandha merek Veeva Systems (VEEV)

The industry-average P/S for Veeva Systems Inc. (VEEV) reflects market valuation dynamics, where the value 14.10 represents the current metric. Business growth relies on the automation of cloud services, which minimizes personnel costs. The company's monopolist status in the pharma sector is cemented by the deep integration of its software into regulatory processes. Veeva Systems Inc. (VEEV) is currently undergoing a risky architectural transformation, implementing artificial intelligence and its own CRM system.

VEEV Rasio rega marang pendapatan Veeva (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Veeva Systems Inc (VEEV)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:VEEV (veeva.com)
Produk merek Veeva

Veeva Systems Inc. (VEEV) maintains a monopoly status within the pharmaceutical software segment, where stringent FDA standards create high barriers to entry, justifying the business's premium valuation. By analyzing the company's current P/S ratio, an investor can weigh market capitalization against actual revenue, allowing them to filter out speculative noise from fundamental growth and avoid purchasing an overvalued asset during a market bubble phase.

Pesaing Veeva Systems Inc.

DOCS (doximity.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan HealthEquity HQY|Koefisien rega marang pendapatan Waystar Health (WAY)|CRVL: Kapitalisasi marang pendapatan|Rega marang dodolan Privia Medical Group|Huron Consulting Group (HURN) - Rasio rega marang pendapatan|CERT - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan OMCL|GDRX (GoodRx Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S SDGR|PHR - Rega marang dodolan|Rasio rega marang pendapatan Omada Health Inc OMDA|EVH - Kapitalisasi marang pendapatan|HSTM - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Definitive Healthcare Corp DH|CCSI (Consensus) - Kapitalisasi marang pendapatan|Agilon Health Corp - Rasio kapitalisasi pasar marang pendapatan|ABSI (Absci) - Multiplikator P/S|soyoung.com (SY) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan nrchealth.com (NRC)|Spok Holdings Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S OPRX (OptimizeRx Corp.)|TBRG - Kapitalisasi marang pendapatan|SLP: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan SOPHiA GENETICS SA SOPH|HCAT (Health Catalyst) - Kapitalisasi marang pendapatan|CCLD (CareCloud) - Rasio rega marang pendapatan|RSSS (Research Solutions, Inc.) - Multiplikator P/S|Rega marang dodolan DLH Holdings Corp DLHC|Multiplikator P/S ONMD|SCNX - Rega marang dodolan|Healthcare Triangle, Inc. - Kapitalisasi marang pendapatan|iSpecimen Inc - Rasio rega marang pendapatan|Bullfrog AI Holdings Inc - Multiplikator P/S|Koefisien rega marang pendapatan SCWorx Inc WORX|MSPR (MSP Recovery Inc) - Kapitalisasi marang pendapatan|ICCT: Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan MEDS|ORGS: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan R1 RCM Inc. (RCM)|Kapitalisasi marang pendapatan Sharecare Inc SHCR|Multiplikator P/S STRM (Streamline Health Solutions)|syrahealth.com (SYRA) - Rega marang dodolan|ApolloMed - Multiplikator P/S|MODN (Model N Inc) - Rasio kapitalisasi marang pendapatan|NXGN (NextGen) - Kapitalisasi marang pendapatan